Qube Research & Technologies LTD Fortress Biotech, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.28 - $0.65 $11 - $26	40 New	40 $0
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $6,327 - $176,198	-8,009 Reduced 12.39%	56,617 $49,000
Q2 2022 Aug 15, 2022	BUY	$0.8 - $1.5 $51,700 - $96,939	64,626 New	64,626 $54,000
Q2 2020 Aug 14, 2020	SELL	$1.83 - $3.16 $353,958 - $611,207	-193,420 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.14 - $2.96 $63,640 - $165,242	55,825 Added 40.57%	193,420 $366,000

Q4 2019 Feb 13, 2020	BUY	$1.25 - $2.57 $171,993 - $353,619	137,595 New	137,595 $354,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.